Skip to main content
. 2018 Feb 15;9(22):16087–16098. doi: 10.18632/oncotarget.24498

Figure 2.

Figure 2

The 18-GEP model applied to the training dataset (A) and then to the validation dataset (B) significantly separates risk groups for meningioma recurrence.